27.04.2017 • News

FDA Warns on Illegal Cancer Treatments

(c) ER_09/Shutterstock
(c) ER_09/Shutterstock

The US Food and Drug Administration (FDA) has sent warning letters to 14 US-based companies it accuses of illegally selling more than 65 products fraudulently claiming to prevent, diagnose, treat or cure cancer.

Products marketed and sold for human consumption or for pets, without FDA approval – usually on websites and social media platforms – include pills, topical creams, ointments, oils, drops, syrups, teas and diagnostics (such as thermography devices). The agency noted that the sellers make illegal, unproven claims regarding preventing, reversing or curing cancer, killing or inhibiting cancer cells or tumors.

In its correspondence, the FDA has requested responses from the 14 companies, asking them to explain how the violations will be corrected. Failure to do so promptly may result in legal action, including product seizure, injunction and/or criminal prosecution, it said.

Over the past decade, the US health watchdog said it has issued more than 90 warning letters in to companies marketing drugs and other products fraudulently claiming to cure cancer. Although many of the companies warned have stopped selling the products, the agency said “numerous unsafe and unapproved products continue to be sold directly to consumers due in part to the ease with which companies can move their marketing operations to new websites.”

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.